Method for optimizing the treatment of chronic myeloid leukemia with ABL tyrosine kinase inhibitors

Details for Australian Patent Application No. 2009313504 (hide)

Owner Novartis AG

Inventors Esposito, Nicola; Izzo, Barbara; Kalebic, Thea; Pane, Fabrizio; Quarantelli, Fabrizio

Agent Davies Collison Cave

Pub. Number AU-A-2009313504

PCT Pub. Number WO2010/054045

Priority 61/112,221 07.11.08 US

Filing date 5 November 2009

Wipo publication date 14 May 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/054045 Priority application(s): WO2010/054045

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313507-Shockwave valvuloplasty catheter system

2009313497-Engine wash system and method